In the pharmaceutical industry, MRP stands for "Maximum Retail Price," which is the highest price at which a product can be sold to the end consumer. The MRP is determined by the manufacturer and includes the cost of the product, as well as any taxes and markups.
The "price to the stokiest (PTS)" is the price at which the manufacturer sells the product to the stokiest, which is a wholesale distributor that supplies the product to retailers. The margin for the stokiest is typically around 10%, which means that the stokiest adds a markup of 10% to the price they pay to the manufacturer in order to cover their own costs and make a profit.
The "price to the retailer (PTR)" is the price at which the stokiest sells the product to the retailer, which is the store or business that sells the product to the end consumer. The margin for the retailer is typically around 20%, which means that the retailer adds a markup of 20% to the price they pay to the stokiest in order to cover their own costs and make a profit.
So, in summary, the MRP is the highest price at which the product can be sold to the end consumer, the PTS is the price at which the manufacturer sells the product to the stokiest with a margin of around 10%, and the PTR is the price at which the stokiest sells the product to the retailer with a margin of around 20%.